1. "Sage Publications Ltd."
Formats
  1. Journal Article (78)
  2. Review (13)
  3. Conference Paper (4)
  4. Meeting Abstract (2)
Groups
  1. Department of Medicine (20)
  2. Population Sciences Research Program (15)
  3. Radiology, Department of (13)
  4. Solid Tumor Oncology Division (13)
  5. Psychiatry and Behavioral Sciences, Department of (11)
  6. Survivorship Research (11)

More Groups

People
  1. David Rottenberg (9)
  2. Stephen Strother (6)
  3. Jennifer Hay (5)
  4. James Moeller (4)
  5. Ronald Blasberg (4)
  6. Julio Arevalo Perez (3)

More People

Years
  1. 2025 (1)
  2. 2024 (5)
  3. 2023 (11)
  4. 2022 (5)
  5. 2021 (9)
  6. 2020 (9)

More Years

Publications
  1. Journal of Cerebral Blood Flow and Metabolism (18)
  2. Therapeutic Advances in Medical Oncology (15)
  3. Journal of Oncology Pharmacy Practice (13)
  4. Journal of Health Psychology (12)
  5. Acta Radiologica (8)
  6. The Neuroradiology Journal (6)

More Publications

Publishers
  1. Sage Publications Ltd. (97)

Results (97)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Efficacy of goserelin in ovarian function suppression and preservation for pre-and perimenopausal breast cancer patients: A systematic review
    Review

    Chen, N.; Audi Blotta, D.; Kim, H. J.; Sayeed, S.; Cannon, J.; Osman, N.; Macrito, R.; Lambertini, M.
    Therapeutic Advances in Medical Oncology (2025)

    Fulltext@MSK | Save
  • A comparative review of Aphexda and Mozobil for mobilization prior to stem cell collection
    Review

    Dietz, L.; Marini, J.; Hashmi, H.; McGann, M.
    Journal of Oncology Pharmacy Practice (2024)

    Fulltext@MSK | Save
  • Magnetic resonance relaxometry in quantitative imaging of brain gliomas: A literature review
    Review

    Chekhonin, I. V.; Cohen, O.; Otazo, R.; Young, R. J.; Holodny, A. I.; Pronin, I. N.
    The Neuroradiology Journal (2024)

    Fulltext@MSK | Save
  • Moderating influences on parents’ fatalistic beliefs about cancer and their association with sun safety behaviors among children of melanoma survivors: Implications for treatment
    Journal Article

    Wu, Y. P.; Tercyak, K. P.; Wankier, A. P.; Brunsgaard, E. K.; Parsons, B. G.; Devine, K. A.; Stump, T. K.; Boucher, K. M.; Hay, J. L.
    Journal of Health Psychology (2024)

    Fulltext@MSK | Save
  • Oncology pharmacy practice in the United States: Results of a comprehensive, nationwide survey
    Journal Article

    Griffin, S. P.; Signorelli, J. R.; Lasko, A.; Andrick, B. J.; Doan, D.; Hough, S.; Riebandt, G.; Harnicar, S.
    Journal of Oncology Pharmacy Practice (2024)

    Fulltext@MSK | Save
  • The safety and efficacy of methylnaltrexone in pediatric oncology patients: A single center experience
    Journal Article

    Koranteng, L.; Mauguen, A.; Butler, M.; Yan, S. Q.; Taylor, D.
    Journal of Oncology Pharmacy Practice (2024)

    Fulltext@MSK | Save
  • Peripheral blood lymphocytes predict clinical outcomes in hormone receptor-positive HER2-negative advanced breast cancer patients treated with CDK4/6 inhibitors
    Journal Article

    Zattarin, E.; Mariani, L.; Menichetti, A.; Leporati, R.; Provenzano, L.; Ligorio, F.; Fucà, G.; Lobefaro, R.; Lalli, L.; Vingiani, A.; more...
    Therapeutic Advances in Medical Oncology (2023)

    Fulltext@MSK | Save
  • 3D Printing in a hospital: Centralized clinical implementation and applications for comprehensive care
    Review

    Hellman, S.; Frisch, P.; Platzman, A.; Booth, P.
    Digital Health (2023)

    Fulltext@MSK | Save
  • Which hematology/oncology patients are high priority for ambulatory clinical pharmacist review? A three-round Delphi survey by the National Comprehensive Cancer Network
    Journal Article

    Booth, J. P.; Kennerly-Shah, J. M.; Kelley, L. R.; Capozzi, D.; Prescott, H. A.; Soefje, S. A.; Pace, M. B.; Barbour, S. Y.; Tizon, R. F.; DeVincenzo, S.; more...
    Journal of Oncology Pharmacy Practice (2023)

    Fulltext@MSK | Save
  • Matching-adjusted indirect comparison of PFS and OS comparing ribociclib plus letrozole versus palbociclib plus letrozole as first-line treatment of HR+/HER2− advanced breast cancer
    Journal Article

    Jhaveri, K.; O’Shaughnessy, J.; Fasching, P. A.; Tolaney, S. M.; Yardley, D. A.; Sharma, V. K.; Biswas, C.; Thuerigen, A.; Pathak, P.; Rugo, H. S.
    Therapeutic Advances in Medical Oncology (2023)

    Fulltext@MSK | Save